nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—HTR6—Raloxifene—osteoporosis	0.335	0.528	CbGbCtD
Cyproheptadine—HTR2B—Raloxifene—osteoporosis	0.3	0.472	CbGbCtD
Cyproheptadine—Agranulocytosis—Zoledronate—osteoporosis	0.00113	0.00382	CcSEcCtD
Cyproheptadine—Oedema—Estropipate—osteoporosis	0.00113	0.00381	CcSEcCtD
Cyproheptadine—Convulsion—Calcitriol—osteoporosis	0.00112	0.0038	CcSEcCtD
Cyproheptadine—Constipation—Etidronic acid—osteoporosis	0.00111	0.00376	CcSEcCtD
Cyproheptadine—Shock—Raloxifene—osteoporosis	0.00107	0.00363	CcSEcCtD
Cyproheptadine—Feeling abnormal—Etidronic acid—osteoporosis	0.00107	0.00363	CcSEcCtD
Cyproheptadine—Chills—Pamidronate—osteoporosis	0.00107	0.00361	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Raloxifene—osteoporosis	0.00107	0.00361	CcSEcCtD
Cyproheptadine—Shock—Ibandronate—osteoporosis	0.00106	0.00359	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Raloxifene—osteoporosis	0.00106	0.00357	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Ibandronate—osteoporosis	0.00105	0.00353	CcSEcCtD
Cyproheptadine—Nausea—Ergocalciferol—osteoporosis	0.00104	0.00352	CcSEcCtD
Cyproheptadine—Urticaria—Etidronic acid—osteoporosis	0.00104	0.0035	CcSEcCtD
Cyproheptadine—Sweating increased—Estradiol—osteoporosis	0.00102	0.00345	CcSEcCtD
Cyproheptadine—Insomnia—Estropipate—osteoporosis	0.00102	0.00344	CcSEcCtD
Cyproheptadine—Tension—Pamidronate—osteoporosis	0.00102	0.00344	CcSEcCtD
Cyproheptadine—Paraesthesia—Estropipate—osteoporosis	0.00101	0.00342	CcSEcCtD
Cyproheptadine—Anorexia—Calcitriol—osteoporosis	0.00101	0.00341	CcSEcCtD
Cyproheptadine—Nervousness—Pamidronate—osteoporosis	0.00101	0.0034	CcSEcCtD
Cyproheptadine—Somnolence—Estropipate—osteoporosis	0.001	0.00339	CcSEcCtD
Cyproheptadine—Dyspepsia—Estropipate—osteoporosis	0.000993	0.00335	CcSEcCtD
Cyproheptadine—Insomnia—Raloxifene—osteoporosis	0.000988	0.00334	CcSEcCtD
Cyproheptadine—Vertigo—Risedronate—osteoporosis	0.000981	0.00331	CcSEcCtD
Cyproheptadine—Syncope—Risedronate—osteoporosis	0.000979	0.00331	CcSEcCtD
Cyproheptadine—Insomnia—Ibandronate—osteoporosis	0.000978	0.0033	CcSEcCtD
Cyproheptadine—Dyspepsia—Alendronate—osteoporosis	0.000978	0.0033	CcSEcCtD
Cyproheptadine—Chills—Zoledronate—osteoporosis	0.000977	0.0033	CcSEcCtD
Cyproheptadine—Fatigue—Estropipate—osteoporosis	0.000972	0.00328	CcSEcCtD
Cyproheptadine—Paraesthesia—Ibandronate—osteoporosis	0.000971	0.00328	CcSEcCtD
Cyproheptadine—Pollakiuria—Estradiol—osteoporosis	0.000969	0.00327	CcSEcCtD
Cyproheptadine—Constipation—Estropipate—osteoporosis	0.000964	0.00326	CcSEcCtD
Cyproheptadine—Dyspepsia—Raloxifene—osteoporosis	0.000962	0.00325	CcSEcCtD
Cyproheptadine—Loss of consciousness—Risedronate—osteoporosis	0.00096	0.00324	CcSEcCtD
Cyproheptadine—Insomnia—Calcitriol—osteoporosis	0.000958	0.00323	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Estradiol—osteoporosis	0.000957	0.00323	CcSEcCtD
Cyproheptadine—Weight increased—Estradiol—osteoporosis	0.000954	0.00322	CcSEcCtD
Cyproheptadine—Agitation—Pamidronate—osteoporosis	0.000954	0.00322	CcSEcCtD
Cyproheptadine—Dyspepsia—Ibandronate—osteoporosis	0.000952	0.00321	CcSEcCtD
Cyproheptadine—Constipation—Alendronate—osteoporosis	0.00095	0.00321	CcSEcCtD
Cyproheptadine—Somnolence—Calcitriol—osteoporosis	0.000941	0.00318	CcSEcCtD
Cyproheptadine—Decreased appetite—Ibandronate—osteoporosis	0.00094	0.00317	CcSEcCtD
Cyproheptadine—Fatigue—Ibandronate—osteoporosis	0.000932	0.00315	CcSEcCtD
Cyproheptadine—Syncope—Pamidronate—osteoporosis	0.000931	0.00314	CcSEcCtD
Cyproheptadine—Leukopenia—Pamidronate—osteoporosis	0.000929	0.00314	CcSEcCtD
Cyproheptadine—Constipation—Ibandronate—osteoporosis	0.000925	0.00312	CcSEcCtD
Cyproheptadine—Decreased appetite—Calcitriol—osteoporosis	0.00092	0.00311	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Estradiol—osteoporosis	0.000917	0.0031	CcSEcCtD
Cyproheptadine—Feeling abnormal—Alendronate—osteoporosis	0.000915	0.00309	CcSEcCtD
Cyproheptadine—Oedema—Ethinyl Estradiol—osteoporosis	0.000914	0.00309	CcSEcCtD
Cyproheptadine—Loss of consciousness—Pamidronate—osteoporosis	0.000912	0.00308	CcSEcCtD
Cyproheptadine—Jaundice—Estradiol—osteoporosis	0.000912	0.00308	CcSEcCtD
Cyproheptadine—Constipation—Calcitriol—osteoporosis	0.000905	0.00306	CcSEcCtD
Cyproheptadine—Convulsion—Pamidronate—osteoporosis	0.000899	0.00304	CcSEcCtD
Cyproheptadine—Tension—Conjugated Estrogens—osteoporosis	0.000896	0.00303	CcSEcCtD
Cyproheptadine—Urticaria—Estropipate—osteoporosis	0.000896	0.00303	CcSEcCtD
Cyproheptadine—Vision blurred—Zoledronate—osteoporosis	0.000894	0.00302	CcSEcCtD
Cyproheptadine—Diarrhoea—Etidronic acid—osteoporosis	0.000892	0.00301	CcSEcCtD
Cyproheptadine—Feeling abnormal—Ibandronate—osteoporosis	0.000891	0.00301	CcSEcCtD
Cyproheptadine—Tremor—Zoledronate—osteoporosis	0.000888	0.003	CcSEcCtD
Cyproheptadine—Nervousness—Conjugated Estrogens—osteoporosis	0.000887	0.00299	CcSEcCtD
Cyproheptadine—Urticaria—Alendronate—osteoporosis	0.000882	0.00298	CcSEcCtD
Cyproheptadine—Shock—Risedronate—osteoporosis	0.000877	0.00296	CcSEcCtD
Cyproheptadine—Agitation—Zoledronate—osteoporosis	0.000871	0.00294	CcSEcCtD
Cyproheptadine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000861	0.00291	CcSEcCtD
Cyproheptadine—Urticaria—Ibandronate—osteoporosis	0.000859	0.0029	CcSEcCtD
Cyproheptadine—Confusional state—Pamidronate—osteoporosis	0.000854	0.00288	CcSEcCtD
Cyproheptadine—Vertigo—Zoledronate—osteoporosis	0.000852	0.00288	CcSEcCtD
Cyproheptadine—Syncope—Zoledronate—osteoporosis	0.00085	0.00287	CcSEcCtD
Cyproheptadine—Leukopenia—Zoledronate—osteoporosis	0.000849	0.00287	CcSEcCtD
Cyproheptadine—Oedema—Pamidronate—osteoporosis	0.000847	0.00286	CcSEcCtD
Cyproheptadine—Urticaria—Calcitriol—osteoporosis	0.000841	0.00284	CcSEcCtD
Cyproheptadine—Hepatitis—Estradiol—osteoporosis	0.000839	0.00283	CcSEcCtD
Cyproheptadine—Palpitations—Zoledronate—osteoporosis	0.000838	0.00283	CcSEcCtD
Cyproheptadine—Shock—Pamidronate—osteoporosis	0.000834	0.00281	CcSEcCtD
Cyproheptadine—Loss of consciousness—Zoledronate—osteoporosis	0.000833	0.00281	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Pamidronate—osteoporosis	0.00083	0.0028	CcSEcCtD
Cyproheptadine—Vomiting—Etidronic acid—osteoporosis	0.000829	0.0028	CcSEcCtD
Cyproheptadine—Tachycardia—Pamidronate—osteoporosis	0.000827	0.00279	CcSEcCtD
Cyproheptadine—Rash—Etidronic acid—osteoporosis	0.000822	0.00278	CcSEcCtD
Cyproheptadine—Convulsion—Zoledronate—osteoporosis	0.000822	0.00277	CcSEcCtD
Cyproheptadine—Dermatitis—Etidronic acid—osteoporosis	0.000821	0.00277	CcSEcCtD
Cyproheptadine—Vertigo—Conjugated Estrogens—osteoporosis	0.00082	0.00277	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Pamidronate—osteoporosis	0.000819	0.00277	CcSEcCtD
Cyproheptadine—Syncope—Conjugated Estrogens—osteoporosis	0.000819	0.00276	CcSEcCtD
Cyproheptadine—Headache—Etidronic acid—osteoporosis	0.000817	0.00276	CcSEcCtD
Cyproheptadine—Asthenia—Estropipate—osteoporosis	0.000809	0.00273	CcSEcCtD
Cyproheptadine—Anorexia—Pamidronate—osteoporosis	0.000808	0.00273	CcSEcCtD
Cyproheptadine—Palpitations—Conjugated Estrogens—osteoporosis	0.000807	0.00272	CcSEcCtD
Cyproheptadine—Insomnia—Risedronate—osteoporosis	0.000806	0.00272	CcSEcCtD
Cyproheptadine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000803	0.00271	CcSEcCtD
Cyproheptadine—Paraesthesia—Risedronate—osteoporosis	0.0008	0.0027	CcSEcCtD
Cyproheptadine—Asthenia—Alendronate—osteoporosis	0.000797	0.00269	CcSEcCtD
Cyproheptadine—Hypotension—Pamidronate—osteoporosis	0.000792	0.00267	CcSEcCtD
Cyproheptadine—Convulsion—Conjugated Estrogens—osteoporosis	0.000791	0.00267	CcSEcCtD
Cyproheptadine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000788	0.00266	CcSEcCtD
Cyproheptadine—Dyspepsia—Risedronate—osteoporosis	0.000785	0.00265	CcSEcCtD
Cyproheptadine—Tinnitus—Estradiol—osteoporosis	0.000783	0.00264	CcSEcCtD
Cyproheptadine—Constipation—Ethinyl Estradiol—osteoporosis	0.000782	0.00264	CcSEcCtD
Cyproheptadine—Confusional state—Zoledronate—osteoporosis	0.00078	0.00263	CcSEcCtD
Cyproheptadine—Asthenia—Ibandronate—osteoporosis	0.000776	0.00262	CcSEcCtD
Cyproheptadine—Nausea—Etidronic acid—osteoporosis	0.000774	0.00261	CcSEcCtD
Cyproheptadine—Oedema—Zoledronate—osteoporosis	0.000774	0.00261	CcSEcCtD
Cyproheptadine—Diarrhoea—Estropipate—osteoporosis	0.000772	0.00261	CcSEcCtD
Cyproheptadine—Fatigue—Risedronate—osteoporosis	0.000768	0.00259	CcSEcCtD
Cyproheptadine—Insomnia—Pamidronate—osteoporosis	0.000766	0.00259	CcSEcCtD
Cyproheptadine—Constipation—Risedronate—osteoporosis	0.000762	0.00257	CcSEcCtD
Cyproheptadine—Shock—Zoledronate—osteoporosis	0.000761	0.00257	CcSEcCtD
Cyproheptadine—Paraesthesia—Pamidronate—osteoporosis	0.000761	0.00257	CcSEcCtD
Cyproheptadine—Diarrhoea—Alendronate—osteoporosis	0.00076	0.00257	CcSEcCtD
Cyproheptadine—Asthenia—Calcitriol—osteoporosis	0.00076	0.00256	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Zoledronate—osteoporosis	0.000758	0.00256	CcSEcCtD
Cyproheptadine—Tachycardia—Zoledronate—osteoporosis	0.000755	0.00255	CcSEcCtD
Cyproheptadine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000753	0.00254	CcSEcCtD
Cyproheptadine—Chills—Estradiol—osteoporosis	0.000753	0.00254	CcSEcCtD
Cyproheptadine—Somnolence—Pamidronate—osteoporosis	0.000753	0.00254	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Zoledronate—osteoporosis	0.000748	0.00253	CcSEcCtD
Cyproheptadine—Diarrhoea—Raloxifene—osteoporosis	0.000747	0.00252	CcSEcCtD
Cyproheptadine—Dyspepsia—Pamidronate—osteoporosis	0.000746	0.00252	CcSEcCtD
Cyproheptadine—Dizziness—Estropipate—osteoporosis	0.000746	0.00252	CcSEcCtD
Cyproheptadine—Oedema—Conjugated Estrogens—osteoporosis	0.000745	0.00252	CcSEcCtD
Cyproheptadine—Diarrhoea—Ibandronate—osteoporosis	0.00074	0.0025	CcSEcCtD
Cyproheptadine—Anorexia—Zoledronate—osteoporosis	0.000738	0.00249	CcSEcCtD
Cyproheptadine—Decreased appetite—Pamidronate—osteoporosis	0.000737	0.00249	CcSEcCtD
Cyproheptadine—Dizziness—Alendronate—osteoporosis	0.000735	0.00248	CcSEcCtD
Cyproheptadine—Shock—Conjugated Estrogens—osteoporosis	0.000733	0.00248	CcSEcCtD
Cyproheptadine—Fatigue—Pamidronate—osteoporosis	0.00073	0.00247	CcSEcCtD
Cyproheptadine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000727	0.00246	CcSEcCtD
Cyproheptadine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000726	0.00245	CcSEcCtD
Cyproheptadine—Constipation—Pamidronate—osteoporosis	0.000725	0.00245	CcSEcCtD
Cyproheptadine—Diarrhoea—Calcitriol—osteoporosis	0.000724	0.00245	CcSEcCtD
Cyproheptadine—Hypotension—Zoledronate—osteoporosis	0.000723	0.00244	CcSEcCtD
Cyproheptadine—Dizziness—Raloxifene—osteoporosis	0.000722	0.00244	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00072	0.00243	CcSEcCtD
Cyproheptadine—Tension—Estradiol—osteoporosis	0.000717	0.00242	CcSEcCtD
Cyproheptadine—Vomiting—Estropipate—osteoporosis	0.000717	0.00242	CcSEcCtD
Cyproheptadine—Dizziness—Ibandronate—osteoporosis	0.000715	0.00241	CcSEcCtD
Cyproheptadine—Rash—Estropipate—osteoporosis	0.000711	0.0024	CcSEcCtD
Cyproheptadine—Dermatitis—Estropipate—osteoporosis	0.00071	0.0024	CcSEcCtD
Cyproheptadine—Anorexia—Conjugated Estrogens—osteoporosis	0.00071	0.0024	CcSEcCtD
Cyproheptadine—Nervousness—Estradiol—osteoporosis	0.00071	0.0024	CcSEcCtD
Cyproheptadine—Urticaria—Risedronate—osteoporosis	0.000708	0.00239	CcSEcCtD
Cyproheptadine—Headache—Estropipate—osteoporosis	0.000707	0.00239	CcSEcCtD
Cyproheptadine—Vomiting—Alendronate—osteoporosis	0.000706	0.00238	CcSEcCtD
Cyproheptadine—Rash—Alendronate—osteoporosis	0.0007	0.00236	CcSEcCtD
Cyproheptadine—Insomnia—Zoledronate—osteoporosis	0.0007	0.00236	CcSEcCtD
Cyproheptadine—Dermatitis—Alendronate—osteoporosis	0.0007	0.00236	CcSEcCtD
Cyproheptadine—Feeling abnormal—Pamidronate—osteoporosis	0.000698	0.00236	CcSEcCtD
Cyproheptadine—Hypotension—Conjugated Estrogens—osteoporosis	0.000696	0.00235	CcSEcCtD
Cyproheptadine—Headache—Alendronate—osteoporosis	0.000696	0.00235	CcSEcCtD
Cyproheptadine—Paraesthesia—Zoledronate—osteoporosis	0.000695	0.00235	CcSEcCtD
Cyproheptadine—Vomiting—Raloxifene—osteoporosis	0.000695	0.00235	CcSEcCtD
Cyproheptadine—Rash—Raloxifene—osteoporosis	0.000689	0.00233	CcSEcCtD
Cyproheptadine—Dermatitis—Raloxifene—osteoporosis	0.000688	0.00232	CcSEcCtD
Cyproheptadine—Somnolence—Zoledronate—osteoporosis	0.000688	0.00232	CcSEcCtD
Cyproheptadine—Vomiting—Ibandronate—osteoporosis	0.000688	0.00232	CcSEcCtD
Cyproheptadine—Tremor—Estradiol—osteoporosis	0.000685	0.00231	CcSEcCtD
Cyproheptadine—Headache—Raloxifene—osteoporosis	0.000684	0.00231	CcSEcCtD
Cyproheptadine—Rash—Ibandronate—osteoporosis	0.000682	0.0023	CcSEcCtD
Cyproheptadine—Dermatitis—Ibandronate—osteoporosis	0.000681	0.0023	CcSEcCtD
Cyproheptadine—Dyspepsia—Zoledronate—osteoporosis	0.000681	0.0023	CcSEcCtD
Cyproheptadine—Headache—Ibandronate—osteoporosis	0.000678	0.00229	CcSEcCtD
Cyproheptadine—Insomnia—Conjugated Estrogens—osteoporosis	0.000674	0.00228	CcSEcCtD
Cyproheptadine—Vomiting—Calcitriol—osteoporosis	0.000673	0.00227	CcSEcCtD
Cyproheptadine—Decreased appetite—Zoledronate—osteoporosis	0.000673	0.00227	CcSEcCtD
Cyproheptadine—Agitation—Estradiol—osteoporosis	0.000672	0.00227	CcSEcCtD
Cyproheptadine—Nausea—Estropipate—osteoporosis	0.00067	0.00226	CcSEcCtD
Cyproheptadine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000669	0.00226	CcSEcCtD
Cyproheptadine—Rash—Calcitriol—osteoporosis	0.000668	0.00225	CcSEcCtD
Cyproheptadine—Fatigue—Zoledronate—osteoporosis	0.000667	0.00225	CcSEcCtD
Cyproheptadine—Dermatitis—Calcitriol—osteoporosis	0.000667	0.00225	CcSEcCtD
Cyproheptadine—Headache—Calcitriol—osteoporosis	0.000663	0.00224	CcSEcCtD
Cyproheptadine—Somnolence—Conjugated Estrogens—osteoporosis	0.000662	0.00224	CcSEcCtD
Cyproheptadine—Constipation—Zoledronate—osteoporosis	0.000662	0.00223	CcSEcCtD
Cyproheptadine—Nausea—Alendronate—osteoporosis	0.00066	0.00223	CcSEcCtD
Cyproheptadine—Vertigo—Estradiol—osteoporosis	0.000657	0.00222	CcSEcCtD
Cyproheptadine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000656	0.00221	CcSEcCtD
Cyproheptadine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000656	0.00221	CcSEcCtD
Cyproheptadine—Syncope—Estradiol—osteoporosis	0.000655	0.00221	CcSEcCtD
Cyproheptadine—Nausea—Raloxifene—osteoporosis	0.000649	0.00219	CcSEcCtD
Cyproheptadine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000648	0.00219	CcSEcCtD
Cyproheptadine—Palpitations—Estradiol—osteoporosis	0.000646	0.00218	CcSEcCtD
Cyproheptadine—Fatigue—Conjugated Estrogens—osteoporosis	0.000642	0.00217	CcSEcCtD
Cyproheptadine—Nausea—Ibandronate—osteoporosis	0.000642	0.00217	CcSEcCtD
Cyproheptadine—Loss of consciousness—Estradiol—osteoporosis	0.000642	0.00217	CcSEcCtD
Cyproheptadine—Asthenia—Risedronate—osteoporosis	0.000639	0.00216	CcSEcCtD
Cyproheptadine—Feeling abnormal—Zoledronate—osteoporosis	0.000638	0.00215	CcSEcCtD
Cyproheptadine—Constipation—Conjugated Estrogens—osteoporosis	0.000637	0.00215	CcSEcCtD
Cyproheptadine—Nausea—Calcitriol—osteoporosis	0.000629	0.00212	CcSEcCtD
Cyproheptadine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000625	0.00211	CcSEcCtD
Cyproheptadine—Urticaria—Zoledronate—osteoporosis	0.000615	0.00208	CcSEcCtD
Cyproheptadine—Diarrhoea—Risedronate—osteoporosis	0.00061	0.00206	CcSEcCtD
Cyproheptadine—Asthenia—Pamidronate—osteoporosis	0.000608	0.00205	CcSEcCtD
Cyproheptadine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000605	0.00204	CcSEcCtD
Cyproheptadine—Confusional state—Estradiol—osteoporosis	0.000601	0.00203	CcSEcCtD
Cyproheptadine—Oedema—Estradiol—osteoporosis	0.000596	0.00201	CcSEcCtD
Cyproheptadine—Urticaria—Conjugated Estrogens—osteoporosis	0.000592	0.002	CcSEcCtD
Cyproheptadine—Dizziness—Risedronate—osteoporosis	0.000589	0.00199	CcSEcCtD
Cyproheptadine—Shock—Estradiol—osteoporosis	0.000587	0.00198	CcSEcCtD
Cyproheptadine—Tachycardia—Estradiol—osteoporosis	0.000582	0.00197	CcSEcCtD
Cyproheptadine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000581	0.00196	CcSEcCtD
Cyproheptadine—Diarrhoea—Pamidronate—osteoporosis	0.00058	0.00196	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Estradiol—osteoporosis	0.000577	0.00195	CcSEcCtD
Cyproheptadine—Rash—Ethinyl Estradiol—osteoporosis	0.000576	0.00195	CcSEcCtD
Cyproheptadine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000576	0.00194	CcSEcCtD
Cyproheptadine—Headache—Ethinyl Estradiol—osteoporosis	0.000573	0.00193	CcSEcCtD
Cyproheptadine—Vomiting—Risedronate—osteoporosis	0.000567	0.00191	CcSEcCtD
Cyproheptadine—Rash—Risedronate—osteoporosis	0.000562	0.0019	CcSEcCtD
Cyproheptadine—Dermatitis—Risedronate—osteoporosis	0.000561	0.0019	CcSEcCtD
Cyproheptadine—Dizziness—Pamidronate—osteoporosis	0.00056	0.00189	CcSEcCtD
Cyproheptadine—Headache—Risedronate—osteoporosis	0.000558	0.00189	CcSEcCtD
Cyproheptadine—Asthenia—Zoledronate—osteoporosis	0.000555	0.00187	CcSEcCtD
Cyproheptadine—Nausea—Ethinyl Estradiol—osteoporosis	0.000543	0.00183	CcSEcCtD
Cyproheptadine—Insomnia—Estradiol—osteoporosis	0.000539	0.00182	CcSEcCtD
Cyproheptadine—Vomiting—Pamidronate—osteoporosis	0.000539	0.00182	CcSEcCtD
Cyproheptadine—Paraesthesia—Estradiol—osteoporosis	0.000536	0.00181	CcSEcCtD
Cyproheptadine—Asthenia—Conjugated Estrogens—osteoporosis	0.000535	0.00181	CcSEcCtD
Cyproheptadine—Rash—Pamidronate—osteoporosis	0.000534	0.0018	CcSEcCtD
Cyproheptadine—Dermatitis—Pamidronate—osteoporosis	0.000534	0.0018	CcSEcCtD
Cyproheptadine—Headache—Pamidronate—osteoporosis	0.000531	0.00179	CcSEcCtD
Cyproheptadine—Somnolence—Estradiol—osteoporosis	0.00053	0.00179	CcSEcCtD
Cyproheptadine—Diarrhoea—Zoledronate—osteoporosis	0.00053	0.00179	CcSEcCtD
Cyproheptadine—Nausea—Risedronate—osteoporosis	0.000529	0.00179	CcSEcCtD
Cyproheptadine—Dyspepsia—Estradiol—osteoporosis	0.000525	0.00177	CcSEcCtD
Cyproheptadine—Decreased appetite—Estradiol—osteoporosis	0.000518	0.00175	CcSEcCtD
Cyproheptadine—Fatigue—Estradiol—osteoporosis	0.000514	0.00174	CcSEcCtD
Cyproheptadine—Dizziness—Zoledronate—osteoporosis	0.000512	0.00173	CcSEcCtD
Cyproheptadine—Constipation—Estradiol—osteoporosis	0.00051	0.00172	CcSEcCtD
Cyproheptadine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00051	0.00172	CcSEcCtD
Cyproheptadine—Nausea—Pamidronate—osteoporosis	0.000503	0.0017	CcSEcCtD
Cyproheptadine—Dizziness—Conjugated Estrogens—osteoporosis	0.000493	0.00166	CcSEcCtD
Cyproheptadine—Vomiting—Zoledronate—osteoporosis	0.000492	0.00166	CcSEcCtD
Cyproheptadine—Feeling abnormal—Estradiol—osteoporosis	0.000491	0.00166	CcSEcCtD
Cyproheptadine—Rash—Zoledronate—osteoporosis	0.000488	0.00165	CcSEcCtD
Cyproheptadine—Dermatitis—Zoledronate—osteoporosis	0.000488	0.00165	CcSEcCtD
Cyproheptadine—Headache—Zoledronate—osteoporosis	0.000485	0.00164	CcSEcCtD
Cyproheptadine—Vomiting—Conjugated Estrogens—osteoporosis	0.000474	0.0016	CcSEcCtD
Cyproheptadine—Urticaria—Estradiol—osteoporosis	0.000474	0.0016	CcSEcCtD
Cyproheptadine—Rash—Conjugated Estrogens—osteoporosis	0.00047	0.00159	CcSEcCtD
Cyproheptadine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000469	0.00159	CcSEcCtD
Cyproheptadine—Headache—Conjugated Estrogens—osteoporosis	0.000467	0.00158	CcSEcCtD
Cyproheptadine—Nausea—Zoledronate—osteoporosis	0.00046	0.00155	CcSEcCtD
Cyproheptadine—Nausea—Conjugated Estrogens—osteoporosis	0.000443	0.00149	CcSEcCtD
Cyproheptadine—Asthenia—Estradiol—osteoporosis	0.000428	0.00144	CcSEcCtD
Cyproheptadine—Diarrhoea—Estradiol—osteoporosis	0.000408	0.00138	CcSEcCtD
Cyproheptadine—Dizziness—Estradiol—osteoporosis	0.000394	0.00133	CcSEcCtD
Cyproheptadine—Vomiting—Estradiol—osteoporosis	0.000379	0.00128	CcSEcCtD
Cyproheptadine—Rash—Estradiol—osteoporosis	0.000376	0.00127	CcSEcCtD
Cyproheptadine—Dermatitis—Estradiol—osteoporosis	0.000376	0.00127	CcSEcCtD
Cyproheptadine—Headache—Estradiol—osteoporosis	0.000374	0.00126	CcSEcCtD
Cyproheptadine—Nausea—Estradiol—osteoporosis	0.000354	0.0012	CcSEcCtD
Cyproheptadine—HTR2A—Signaling Pathways—NFATC1—osteoporosis	3.18e-05	0.000462	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CNR2—osteoporosis	3.18e-05	0.000461	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NFATC1—osteoporosis	3.18e-05	0.000461	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PTHLH—osteoporosis	3.17e-05	0.00046	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—BMP2—osteoporosis	3.17e-05	0.00046	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NFATC1—osteoporosis	3.17e-05	0.000459	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—DKK1—osteoporosis	3.16e-05	0.000458	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NFATC1—osteoporosis	3.16e-05	0.000458	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	3.15e-05	0.000457	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—DKK1—osteoporosis	3.15e-05	0.000457	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—DKK1—osteoporosis	3.14e-05	0.000456	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—KL—osteoporosis	3.14e-05	0.000455	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—DKK1—osteoporosis	3.13e-05	0.000454	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—ENO1—osteoporosis	3.13e-05	0.000454	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NFATC1—osteoporosis	3.12e-05	0.000453	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—FGB—osteoporosis	3.12e-05	0.000452	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—DKK1—osteoporosis	3.1e-05	0.00045	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—FGB—osteoporosis	3.1e-05	0.00045	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—WNT1—osteoporosis	3.09e-05	0.000449	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PSMA2—osteoporosis	3.08e-05	0.000447	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PSMA5—osteoporosis	3.08e-05	0.000447	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—POMC—osteoporosis	3.06e-05	0.000444	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—WNT1—osteoporosis	3.04e-05	0.000441	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—WNT1—osteoporosis	3.03e-05	0.00044	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—WNT1—osteoporosis	3.03e-05	0.000439	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—WNT1—osteoporosis	3.02e-05	0.000438	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PSMA2—osteoporosis	3.01e-05	0.000436	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PSMA5—osteoporosis	3.01e-05	0.000436	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—POMC—osteoporosis	3.01e-05	0.000436	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—FGA—osteoporosis	3.01e-05	0.000436	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PSMA2—osteoporosis	2.99e-05	0.000434	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PSMA5—osteoporosis	2.99e-05	0.000434	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL6R—osteoporosis	2.99e-05	0.000433	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—WNT1—osteoporosis	2.99e-05	0.000433	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—ADCY5—osteoporosis	2.96e-05	0.00043	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—FGA—osteoporosis	2.96e-05	0.000429	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—FGA—osteoporosis	2.95e-05	0.000428	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—FGA—osteoporosis	2.94e-05	0.000427	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—FGA—osteoporosis	2.93e-05	0.000426	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—ADCY5—osteoporosis	2.92e-05	0.000423	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—ADCY5—osteoporosis	2.91e-05	0.000422	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—FGA—osteoporosis	2.91e-05	0.000422	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	2.9e-05	0.000421	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—ADCY5—osteoporosis	2.89e-05	0.00042	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	2.86e-05	0.000415	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CALCA—osteoporosis	2.8e-05	0.000407	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PTHLH—osteoporosis	2.8e-05	0.000406	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—BMP2—osteoporosis	2.8e-05	0.000406	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CALCA—osteoporosis	2.79e-05	0.000405	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PTHLH—osteoporosis	2.75e-05	0.000399	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—BMP2—osteoporosis	2.75e-05	0.000399	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PTHLH—osteoporosis	2.74e-05	0.000398	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—BMP2—osteoporosis	2.74e-05	0.000398	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PTHLH—osteoporosis	2.74e-05	0.000397	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—BMP2—osteoporosis	2.74e-05	0.000397	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—FGB—osteoporosis	2.74e-05	0.000397	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—POMC—osteoporosis	2.73e-05	0.000397	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PTHLH—osteoporosis	2.73e-05	0.000396	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—BMP2—osteoporosis	2.73e-05	0.000396	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—POMC—osteoporosis	2.72e-05	0.000395	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PTHLH—osteoporosis	2.7e-05	0.000392	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—BMP2—osteoporosis	2.7e-05	0.000392	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—ADCY5—osteoporosis	2.69e-05	0.000391	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—FGB—osteoporosis	2.69e-05	0.000391	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—FGB—osteoporosis	2.69e-05	0.00039	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—FGB—osteoporosis	2.68e-05	0.000388	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—FGB—osteoporosis	2.67e-05	0.000387	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—FGB—osteoporosis	2.64e-05	0.000383	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PSMA2—osteoporosis	2.64e-05	0.000383	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PSMA5—osteoporosis	2.64e-05	0.000383	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—SPP1—osteoporosis	2.61e-05	0.000378	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PSMA2—osteoporosis	2.6e-05	0.000377	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PSMA5—osteoporosis	2.6e-05	0.000377	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PSMA5—osteoporosis	2.59e-05	0.000376	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PSMA2—osteoporosis	2.59e-05	0.000376	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PSMA5—osteoporosis	2.58e-05	0.000375	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PSMA2—osteoporosis	2.58e-05	0.000375	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PSMA2—osteoporosis	2.58e-05	0.000374	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PSMA5—osteoporosis	2.58e-05	0.000374	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PSMA2—osteoporosis	2.55e-05	0.00037	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PSMA5—osteoporosis	2.55e-05	0.00037	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—KL—osteoporosis	2.55e-05	0.000369	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—KL—osteoporosis	2.53e-05	0.000367	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—CYP19A1—osteoporosis	2.5e-05	0.000363	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—POMC—osteoporosis	2.48e-05	0.00036	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—POMC—osteoporosis	2.47e-05	0.000358	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CALCA—osteoporosis	2.46e-05	0.000357	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—ADCY5—osteoporosis	2.46e-05	0.000357	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL6R—osteoporosis	2.42e-05	0.000351	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CALCA—osteoporosis	2.42e-05	0.000351	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CALCA—osteoporosis	2.42e-05	0.000351	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL6R—osteoporosis	2.41e-05	0.00035	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CALCA—osteoporosis	2.41e-05	0.00035	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CALCA—osteoporosis	2.4e-05	0.000348	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—POMC—osteoporosis	2.4e-05	0.000348	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—SPP1—osteoporosis	2.38e-05	0.000345	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CALCA—osteoporosis	2.38e-05	0.000345	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—POMC—osteoporosis	2.36e-05	0.000343	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—POMC—osteoporosis	2.36e-05	0.000342	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IRS2—osteoporosis	2.36e-05	0.000342	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—POMC—osteoporosis	2.35e-05	0.000341	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—POMC—osteoporosis	2.34e-05	0.00034	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—POMC—osteoporosis	2.32e-05	0.000336	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—LEP—osteoporosis	2.31e-05	0.000335	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—KL—osteoporosis	2.23e-05	0.000324	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—ESR1—osteoporosis	2.2e-05	0.00032	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—KL—osteoporosis	2.2e-05	0.000319	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—KL—osteoporosis	2.19e-05	0.000318	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—KL—osteoporosis	2.19e-05	0.000317	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—KL—osteoporosis	2.18e-05	0.000316	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—POMC—osteoporosis	2.18e-05	0.000316	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—KL—osteoporosis	2.16e-05	0.000313	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IRS2—osteoporosis	2.15e-05	0.000312	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—POMC—osteoporosis	2.14e-05	0.000311	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—POMC—osteoporosis	2.14e-05	0.000311	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—POMC—osteoporosis	2.13e-05	0.00031	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—POMC—osteoporosis	2.13e-05	0.000309	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL6R—osteoporosis	2.13e-05	0.000309	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—POMC—osteoporosis	2.11e-05	0.000306	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—LEP—osteoporosis	2.11e-05	0.000305	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL6R—osteoporosis	2.09e-05	0.000304	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL6R—osteoporosis	2.09e-05	0.000303	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL6R—osteoporosis	2.08e-05	0.000302	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL6R—osteoporosis	2.07e-05	0.000301	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IRS1—osteoporosis	2.06e-05	0.000299	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL6R—osteoporosis	2.05e-05	0.000298	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—ADCY5—osteoporosis	2.04e-05	0.000296	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—GPX1—osteoporosis	2.04e-05	0.000295	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—ESR1—osteoporosis	2.01e-05	0.000292	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.99e-05	0.000289	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.98e-05	0.000288	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—POMC—osteoporosis	1.98e-05	0.000287	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL6R—osteoporosis	1.93e-05	0.00028	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.93e-05	0.00028	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.92e-05	0.000278	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IGF1—osteoporosis	1.91e-05	0.000277	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—MTHFR—osteoporosis	1.88e-05	0.000273	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IRS1—osteoporosis	1.88e-05	0.000273	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—POMC—osteoporosis	1.81e-05	0.000262	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.76e-05	0.000256	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.75e-05	0.000254	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.74e-05	0.000253	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.74e-05	0.000252	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.74e-05	0.000252	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.72e-05	0.00025	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ADCY5—osteoporosis	1.72e-05	0.000249	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ADCY5—osteoporosis	1.71e-05	0.000249	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ADCY5—osteoporosis	1.71e-05	0.000248	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—LEP—osteoporosis	1.71e-05	0.000248	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—LEP—osteoporosis	1.7e-05	0.000246	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SPP1—osteoporosis	1.69e-05	0.000246	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ADCY5—osteoporosis	1.69e-05	0.000245	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.67e-05	0.000242	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SPP1—osteoporosis	1.66e-05	0.000241	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SPP1—osteoporosis	1.66e-05	0.000241	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SPP1—osteoporosis	1.65e-05	0.00024	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SPP1—osteoporosis	1.64e-05	0.000237	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.63e-05	0.000237	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.62e-05	0.000235	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IRS2—osteoporosis	1.53e-05	0.000222	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.52e-05	0.000221	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.52e-05	0.00022	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.51e-05	0.000219	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IRS2—osteoporosis	1.5e-05	0.000218	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—POMC—osteoporosis	1.5e-05	0.000218	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IRS2—osteoporosis	1.5e-05	0.000218	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—LEP—osteoporosis	1.5e-05	0.000217	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IRS2—osteoporosis	1.49e-05	0.000217	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IRS2—osteoporosis	1.48e-05	0.000215	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—LEP—osteoporosis	1.47e-05	0.000214	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—LEP—osteoporosis	1.47e-05	0.000214	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—LEP—osteoporosis	1.47e-05	0.000213	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—POMC—osteoporosis	1.47e-05	0.000213	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—LEP—osteoporosis	1.46e-05	0.000212	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—POMC—osteoporosis	1.46e-05	0.000212	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—IL6—osteoporosis	1.46e-05	0.000211	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—LEP—osteoporosis	1.45e-05	0.00021	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—ESR1—osteoporosis	1.43e-05	0.000208	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.43e-05	0.000208	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.42e-05	0.000207	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IGF1—osteoporosis	1.41e-05	0.000205	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.41e-05	0.000204	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ESR1—osteoporosis	1.41e-05	0.000204	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.4e-05	0.000204	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ESR1—osteoporosis	1.4e-05	0.000203	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ESR1—osteoporosis	1.4e-05	0.000203	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ESR1—osteoporosis	1.38e-05	0.000201	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IRS1—osteoporosis	1.34e-05	0.000194	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL6—osteoporosis	1.33e-05	0.000193	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IRS1—osteoporosis	1.32e-05	0.000191	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IRS1—osteoporosis	1.31e-05	0.000191	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IRS1—osteoporosis	1.31e-05	0.00019	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IRS1—osteoporosis	1.3e-05	0.000189	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IRS1—osteoporosis	1.29e-05	0.000187	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—POMC—osteoporosis	1.29e-05	0.000187	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—POMC—osteoporosis	1.27e-05	0.000184	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—POMC—osteoporosis	1.26e-05	0.000183	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—POMC—osteoporosis	1.26e-05	0.000183	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—POMC—osteoporosis	1.26e-05	0.000182	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6R—osteoporosis	1.26e-05	0.000182	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—POMC—osteoporosis	1.24e-05	0.000181	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IGF1—osteoporosis	1.24e-05	0.00018	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6R—osteoporosis	1.24e-05	0.000179	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6R—osteoporosis	1.23e-05	0.000179	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6R—osteoporosis	1.23e-05	0.000178	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6R—osteoporosis	1.23e-05	0.000178	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IGF1—osteoporosis	1.22e-05	0.000177	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IGF1—osteoporosis	1.22e-05	0.000176	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6R—osteoporosis	1.21e-05	0.000176	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IGF1—osteoporosis	1.21e-05	0.000176	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IGF1—osteoporosis	1.21e-05	0.000175	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IGF1—osteoporosis	1.2e-05	0.000174	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MYC—osteoporosis	1.15e-05	0.000166	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TGFB1—osteoporosis	1.14e-05	0.000166	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL6—osteoporosis	1.08e-05	0.000157	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL6—osteoporosis	1.07e-05	0.000156	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MYC—osteoporosis	1.05e-05	0.000152	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TGFB1—osteoporosis	1.04e-05	0.000151	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL6—osteoporosis	9.47e-06	0.000137	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL6—osteoporosis	9.32e-06	0.000135	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL6—osteoporosis	9.3e-06	0.000135	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL6—osteoporosis	9.27e-06	0.000135	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL6—osteoporosis	9.24e-06	0.000134	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL6—osteoporosis	9.15e-06	0.000133	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL6—osteoporosis	8.61e-06	0.000125	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MYC—osteoporosis	8.48e-06	0.000123	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TGFB1—osteoporosis	8.46e-06	0.000123	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MYC—osteoporosis	8.43e-06	0.000122	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	8.41e-06	0.000122	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL6—osteoporosis	7.86e-06	0.000114	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MYC—osteoporosis	7.44e-06	0.000108	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TGFB1—osteoporosis	7.43e-06	0.000108	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MYC—osteoporosis	7.32e-06	0.000106	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MYC—osteoporosis	7.31e-06	0.000106	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TGFB1—osteoporosis	7.31e-06	0.000106	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TGFB1—osteoporosis	7.29e-06	0.000106	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MYC—osteoporosis	7.28e-06	0.000106	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TGFB1—osteoporosis	7.27e-06	0.000105	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MYC—osteoporosis	7.26e-06	0.000105	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TGFB1—osteoporosis	7.24e-06	0.000105	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MYC—osteoporosis	7.19e-06	0.000104	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TGFB1—osteoporosis	7.17e-06	0.000104	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6—osteoporosis	6.37e-06	9.25e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6—osteoporosis	6.34e-06	9.2e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6—osteoporosis	5.6e-06	8.12e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6—osteoporosis	5.51e-06	7.99e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6—osteoporosis	5.49e-06	7.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6—osteoporosis	5.48e-06	7.95e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6—osteoporosis	5.46e-06	7.92e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6—osteoporosis	5.41e-06	7.84e-05	CbGpPWpGaD
